Palvella Therapeutics, Inc. (PVLA) Operating income 2016–2025
Palvella Therapeutics, Inc. (PVLA) annual operating income history from SEC filings — each fiscal year as reported.
-$38.6MFY2025 · since FY2016: -$22.8M → -$38.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.6M | -173.9% |
| FY2024 | -$14.1M | -18.8% |
| FY2023 | -$11.9M | +72.7% |
| FY2022 | -$43.5M | +16.1% |
| FY2021 | -$51.8M | -52.8% |
| FY2020 | -$33.9M | -24.9% |
| FY2019 | -$27.2M | +11.9% |
| FY2018 | -$30.8M | -111.3% |
| FY2017 | -$14.6M | +35.9% |
| FY2016 | -$22.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice